Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

~79 mi. (Kazan, Russia, +176 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2646)

Endometrial Carcinoma, +1 more condition

chemotherapy, +2 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

~79 mi. (Kazan, Russia, +158 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1911)

Non-Small Cell Lung Carcinoma

olaparib, +4 more drugs

chemotherapy, +3 more types

A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy

~79 mi. (Kazan, Russia, +260 more cities)

Republican Clinical Oncological Dispensary of the Ministry of Healthcare; Chemotherapy department

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

immunotherapy, +1 more type

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)

~79 mi. (Kazan, Russia, +45 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1509)

Esophageal Squamous Cell Carcinoma

cisplatin, +5 more drugs

chemotherapy, +2 more types

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003)

~79 mi. (Kazan, Russia, +93 more cities)

Republican Clinical Oncology Dispensary ( Site 0805)

PD-L1 High Expression (TPS >= 1%), +1 more biomarker

Non-Small Cell Lung Carcinoma

vibostolimab/pembrolizumab MK-7684A

immunotherapy

Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)

~79 mi. (Kazan, Russia, +122 more cities)

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1814)

Small Cell Lung Carcinoma

etoposide, +5 more drugs

chemotherapy, +3 more types

Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)

~79 mi. (Kazan, Russia, +150 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1000)

Head and Neck Squamous Cell Carcinoma

cisplatin, +2 more drugs

chemotherapy, +2 more types

A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy

~79 mi. (Kazan, Russia, +179 more cities)

Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic

Esophageal Squamous Cell Carcinoma

atezolizumab, +1 more drug

immunotherapy

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

~79 mi. (Kazan, Russia, +127 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2609)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type

Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)

~79 mi. (Kazan, Russia, +126 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0412)

Adenocarcinoma of the Gastroesophageal Junction, +1 more condition

FOLFOX regimen, +3 more drugs

chemotherapy, +2 more types

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

~79 mi. (Kazan, Russia, +67 more cities)

Republican Clinical Oncology Dispensary-Chemotherapy #1 ( Site 1425)

Non-Squamous Non-Small Cell Lung Carcinoma, +1 more condition

carboplatin, +5 more drugs

chemotherapy, +1 more type

Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)

~79 mi. (Kazan, Russia, +145 more cities)

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 2001)

Non-Small Cell Lung Carcinoma

pembrolizumab, +1 more drug

immunotherapy, +2 more types